Analyze Diet

Journal of veterinary pharmacology and therapeutics.

Periodical
Pharmacology
Therapeutics
Veterinary Medicine
Drug Therapy
Publisher:
Blackwell Scientific Publications.
Frequency: Bimonthly
Country: England
Language: English
Author(s):
American College of Veterinary Pharmacology & Therapeutics., Association for Veterinary Clinical Pharmacology and Therapeutics., European Association for Veterinary Pharmacology and Toxicology.
Start Year:1978 -
ISSN:
0140-7783 (Print)
1365-2885 (Electronic)
0140-7783 (Linking)
Impact Factor
1.3
2022
NLM ID:7910920
(DNLM):J41230000(s)
(OCoLC):04580359
Coden:JVPTD9
Classification:W1 JO97Q
Effects of muscarinic receptor antagonists on acetylcholine-induced contractions of jejunal smooth muscle in horses.
Journal of veterinary pharmacology and therapeutics    August 21, 2011   Volume 35, Issue 4 313-318 doi: 10.1111/j.1365-2885.2011.01330.x
Teixeira-Neto FJ, McDonell WN, Black WD, Harris W, Grovum L.This study investigated the effects of a muscarinic type 1 (M(1)), 2 (M(2)), and 3 (M(3)) antagonists (4-DAMP, pirenzepine, and methoctramine, respectively) on acetylcholine (Ach)-induced contractions of longitudinal jejunal muscle strips of horses. Strips were irrigated with Krebs-Henseleit solution gassed with 95% O(2) and 5% CO(2), and the developed tension in response to Ach was recorded before and after incubation with increasing concentrations of 4-DAMP (10(-8)-10(-6) M), pirenzepine (10(-6)-10(-4) M), and methoctramine (10(-5)-10(-3) M). When competitive antagonism was characterized, th...
Toltrazuril sulfone sodium salt: synthesis, analytical detection, and pharmacokinetics in the horse.
Journal of veterinary pharmacology and therapeutics    June 17, 2011   Volume 35, Issue 3 265-274 doi: 10.1111/j.1365-2885.2011.01315.x
Dirikolu L, Karpiesiuk W, Lehner AF, Tobin T.Toltrazuril sulfone (ponazuril) is a triazine-based antiprotozoal agent with clinical application in the treatment of equine protozoal myeloencephalomyelitis (EPM). In this study, we synthesized and determined the bioavailability of a sodium salt formulation of toltrazuril sulfone that can be used for the treatment and prophylaxis of EPM in horses. Toltrazuril sulfone sodium salt was rapidly absorbed, with a mean peak plasma concentration of 2400 ± 169 (SEM) ng/mL occurring at 8 h after oral-mucosal dosing and was about 56% bioavailable compared with the i.v. administration of toltrazuril sul...
Plasma and pulmonary disposition of ceftiofur and its metabolites after intramuscular administration of ceftiofur crystalline free acid in weanling foals.
Journal of veterinary pharmacology and therapeutics    May 24, 2011   Volume 35, Issue 3 259-264 doi: 10.1111/j.1365-2885.2011.01311.x
Credille BC, Giguère S, Berghaus LJ, Burton AJ, Sturgill TL, Grover GS, Donecker JM, Brown SA.The objectives of this study were to determine the plasma and pulmonary disposition of ceftiofur crystalline free acid (CCFA) in weanling foals and to compare the plasma pharmacokinetic profile of weanling foals to that of adult horses. A single dose of CCFA was administered intramuscularly to six weanling foals and six adult horses at a dose of 6.6 mg/kg of body weight. Concentrations of desfuroylceftiofur acetamide (DCA) were determined in the plasma of all animals, and in pulmonary epithelial lining fluid (PELF) and bronchoalveolar lavage (BAL) cells of foals. After intramuscular (IM) admin...
Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
Journal of veterinary pharmacology and therapeutics    April 16, 2011   Volume 34, Issue 3 252-258 doi: 10.1111/j.1365-2885.2010.01217.x
Wearn JM, Crisman MV, Davis JL, Geor RJ, Hodgson DR, Suagee JK, Ashraf-Khorassani M, McCutcheon LJ.Pioglitazone is a thiazolidinedione class of antidiabetic agent with proven efficacy in increasing insulin sensitivity in humans with noninsulin-dependent diabetes mellitus, a syndrome of insulin resistance sharing similarities with equine metabolic syndrome. The purpose of this study was to determine the pharmacokinetics of pioglitazone in adult horses following multiple oral dose administration. Pioglitazone hydrochloride (1 mg/kg) was administered orally for 11 doses at 24-h intervals, and plasma samples were collected. Initially, a pilot study was performed using one horse; and thereafter ...
Pharmacokinetics and metabolism of dantrolene in horses.
Journal of veterinary pharmacology and therapeutics    April 16, 2011   Volume 34, Issue 3 238-246 doi: 10.1111/j.1365-2885.2010.01214.x
DiMaio Knych HK, Arthur RM, Taylor A, Moeller BC, Stanley SD.Dantrolene is a skeletal muscle relaxant used commonly in performance horses to prevent exertional rhabdomyolysis. The goal of the study reported here was to begin to characterize cytochrome P450-mediated metabolism of dantrolene in the horse and describe the pharmacokinetics of the compound, formulated as a capsule or a compounded paste formulation, following oral administration. Dantrolene is rapidly metabolized to 5-hydroxydantrolene both in vivo and in vitro. Preliminary work with equine liver microsomes suggest that two enzymes are responsible for the metabolism of dantrolene, as evidence...
Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.
Journal of veterinary pharmacology and therapeutics    April 16, 2011   Volume 34, Issue 3 232-237 doi: 10.1111/j.1365-2885.2010.01213.x
Williams MM, Davis EG, KuKanich B.The objective of the study was to assess the pharmacokinetics of terbinafine administered orally to horses and Greyhound dogs. A secondary objective was to assess terbinafine metabolites. Six healthy horses and six healthy Greyhound dogs were included in the pharmacokinetic data. The targeted dose of terbinafine was 20 and 30 mg/kg for horses and dogs, respectively. Blood was collected at predetermined intervals for the quantification of terbinafine concentrations with liquid chromatography and mass spectrometry. The half-life (geometric mean) was 8.1 and 8.6 h for horses and Greyhounds, respe...
Feasibility of the Ussing chamber technique for the determination of in vitro jejunal permeability of passively absorbed compounds in different animal species.
Journal of veterinary pharmacology and therapeutics    April 16, 2011   Volume 34, Issue 3 290-297 doi: 10.1111/j.1365-2885.2010.01218.x
Neirinckx E, Vervaet C, Michiels J, De Smet S, Van den Broeck W, Remon JP, De Backer P, Croubels S.The aim of this study was to assess the feasibility of the Ussing chamber technique for the determination of the jejunal permeability of passively absorbed, high permeability model compounds (acetaminophen and ketoprofen) in different animal species. Additionally, electrophysiological measurements and histological examination of pre- and post-incubation tissue specimens were performed. Apparent permeability coefficients of turkey and dog jejunum were low and highly variable due to tissue fragility caused by differences in thickness of the remaining intestinal layers after stripping and resulti...
Plasma concentrations of testosterone and nandrolone in racing and nonracing intact male horses.
Journal of veterinary pharmacology and therapeutics    April 12, 2011   Volume 35, Issue 2 132-138 doi: 10.1111/j.1365-2885.2011.01295.x
Soma LR, Uboh CE, You Y, Guan F, McDonnell S.Pennsylvania (PA) State Racing Commissions regulate the endogenous androgenic steroid, testosterone (TES), in racing intact males (RIM) by quantification of TES in post-race samples. Post-race plasma samples (2209) collected between March 2008 and November 2010 were analyzed for TES, nandrolone (NAN), and other anabolic steroids (ABS). Of the 2209 plasma samples, 2098 had quantifiable TES ≥ 25 pg/mL. Plasma (mean ± SD) concentrations of TES and NAN in RIM were 329.2 ± 266.4 and 96.0 ± 67.8 pg/mL, respectively. Only 64.6% of RIM had quantifiable concentration of NAN, and there was no relat...
Plasma pharmacokinetics, pulmonary distribution, and in vitro activity of gamithromycin in foals.
Journal of veterinary pharmacology and therapeutics    March 28, 2011   Volume 35, Issue 1 59-66 doi: 10.1111/j.1365-2885.2011.01292.x
Berghaus LJ, Giguère S, Sturgill TL, Bade D, Malinski TJ, Huang R.The objectives of this study were to determine the plasma and pulmonary disposition of gamithromycin in foals and to investigate the in vitro activity of the drug against Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) and Rhodococcus equi. A single dose of gamithromycin (6 mg/kg of body weight) was administered intramuscularly. Concentrations of gamithromycin in plasma, pulmonary epithelial lining fluid (PELF), bronchoalveolar lavage (BAL) cells, and blood neutrophils were determined using HPLC with tandem mass spectrometry detection. The minimum inhibitory concentration of gamithr...
Effects of two methods of administration on the pharmacokinetics of ceftiofur crystalline free acid in horses.
Journal of veterinary pharmacology and therapeutics    March 15, 2011   Volume 34, Issue 2 193-196 doi: 10.1111/j.1365-2885.2010.01224.x
Giguère S, Sturgill TL, Berghaus LJ, Grover GS, Brown SA.No abstract available
Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
Journal of veterinary pharmacology and therapeutics    March 11, 2011   Volume 35, Issue 1 52-58 doi: 10.1111/j.1365-2885.2011.01284.x
Davis JL, Messenger KM, LaFevers DH, Barlow BM, Posner LP.The purpose of this study was to determine the pharmacokinetics of buprenorphine following intravenous (i.v.) and intramuscular (i.m.) administration in horses. Six horses received i.v. or i.m. buprenorphine (0.005 mg/kg) in a randomized, crossover design. Plasma samples were collected at predetermined times and horses were monitored for adverse reactions. Buprenorphine concentrations were measured using ultra-performance liquid chromatography with electrospray ionization mass spectrometry. Following i.v. administration, clearance was 7.97±5.16 mL/kg/min, and half-life (T(1/2)) was 3.58 h (ha...
Pharmacokinetics of glycopyrrolate following intravenous administration in the horse.
Journal of veterinary pharmacology and therapeutics    March 2, 2011   Volume 34, Issue 6 605-608 doi: 10.1111/j.1365-2885.2011.01272.x
Rumpler MJ, Sams RA, Colahan P.No abstract available
An interlaboratory study of the pharmacokinetics of testosterone following intramuscular administration to Thoroughbred horses.
Journal of veterinary pharmacology and therapeutics    March 2, 2011   Volume 34, Issue 6 588-593 doi: 10.1111/j.1365-2885.2011.01277.x
Moeller BC, Sams RA, Guinjab-Cagmat J, Szabo NJ, Colahan P, Stanley SD.Testosterone is an anabolic androgenic steroid (AAS) that is endogenously produced by both male and female horses that also has the potential for abuse when administered exogenously to race horses. To recommend appropriate withdrawal guidelines so that veterinarians can discontinue therapeutic use prior to competition, the pharmacokinetics and elimination of testosterone were investigated. An aqueous testosterone suspension was administered intramuscularly in the neck of Thoroughbred horses (n = 20). The disposition of testosterone from this formulation was characterized by an initial, rapid a...
Doping control in horses: housing conditions and oral recycling of flunixin by ingestion of contaminated straw.
Journal of veterinary pharmacology and therapeutics    February 16, 2011   Volume 34, Issue 6 612-614 doi: 10.1111/j.1365-2885.2011.01276.x
Popot MA, Garcia P, Bonnaire Y.No abstract available
Pharmacokinetics of ceftiofur crystalline-free acid sterile suspension in the equine.
Journal of veterinary pharmacology and therapeutics    February 16, 2011   Volume 34, Issue 5 476-481 doi: 10.1111/j.1365-2885.2011.01266.x
Collard WT, Cox SR, Lesman SP, Grover GS, Boucher JF, Hallberg JW, Robinson JA, Brown SA.Absolute bioavailability and dose proportionality studies were performed with ceftiofur in horses. In the absolute bioavailability study, thirty animals received either an intravenous dose of ceftiofur sodium at 1.0 mg/kg or an intramuscular (i.m.) dose of ceftiofur crystalline-free acid (CCFA) at 6.6 mg/kg. In the dose proportionality study, 48 animals received daily i.m. ceftiofur sodium injections at 1.0 mg/kg for ten doses or two doses of CCFA separated by 96 h, with CCFA doses of 3.3, 6.6, or 13.2 mg/kg. Noncompartmental and mixed-effect modeling procedures were used to assess pharmacokin...
Efficacy of a 2-dose regimen of a sustained release ceftiofur suspension in horses with Streptococcus equi subsp. zooepidemicus bronchopneumonia.
Journal of veterinary pharmacology and therapeutics    February 9, 2011   Volume 34, Issue 5 442-447 doi: 10.1111/j.1365-2885.2011.01267.x
McClure S, Sibert G, Hallberg J, Bade D.The efficacy and safety of sustained release ceftiofur administered twice, 4 days apart, for treatment of horses with naturally acquired Streptococcus equi subsp. zooepidemicus (Strep. zoo.) pneumonia was evaluated in a multicenter, placebo-controlled, double-blinded, randomized clinical trial. The study included 373 horses (278 treated and 95 placebos) with naturally acquired pneumonia. Inclusion in the statistical analyses for treatment efficacy for Strep. zoo. required recovery of ≥10(4) CFU/mL of Strep. zoo. on the primary isolation plate which resulted in 201 cases (145 treated and 56 p...
Bioavailability of detomidine administered sublingually to horses as an oromucosal gel.
Journal of veterinary pharmacology and therapeutics    January 12, 2011   Volume 34, Issue 1 76-81 doi: 10.1111/j.1365-2885.2010.01193.x
Kaukinen H, Aspegrén J, Hyyppä S, Tamm L, Salonen JS.The objective of the study was to determine the absorption, bioavailability and sedative effect of detomidine administered to horses as an oromucosal gel compared to intravenous and intramuscular administration of detomidine injectable solution. The study was open and randomized, with three sequences crossover design. Nine healthy horses were given 40 μg/kg detomidine intravenously, intramuscularly or administered under the tongue with a 7-day wash-out period between treatments. Blood samples were collected before and after drug administration for the measurement of detomidine concentration...
Pharmacokinetics of yohimbine following intravenous administration to horses.
Journal of veterinary pharmacology and therapeutics    January 12, 2011   Volume 34, Issue 1 58-63 doi: 10.1111/j.1365-2885.2010.01194.x
Dimaio Knych HK, Steffey EP, Deuel JL, Shepard RA, Stanley SD.Yohimbine is an alpha 2 adrenergic receptor antagonist used most commonly in veterinary medicine to reverse the effects of the alpha 2 receptor agonists, xylazine and detomidine. Most notably, yohimbine has been shown to counteract the CNS depressant effects of alpha 2 receptor agonists in a number of species. The recent identification of a yohimbine positive urine sample collected from a horse racing in California has led to the investigation of the pharmacokinetics of this compound. Eight healthy adult horses received a single intravenous dose of 0.12 mg/kg yohimbine. Blood samples were co...
The pharmacokinetics and in vitro cyclooxygenase selectivity of deracoxib in horses.
Journal of veterinary pharmacology and therapeutics    January 12, 2011   Volume 34, Issue 1 12-16 doi: 10.1111/j.1365-2885.2010.01185.x
Davis JL, Marshall JF, Papich MG, Blikslager AT, Campbell NB.The purpose of this study was to determine the pharmacokinetics of deracoxib following oral administration to horses. In addition, in vitro equine whole blood cyclooxygenase (COX) selectivity assays were performed. Six healthy adult horses were administered deracoxib (2 mg/kg) orally. Plasma samples were collected prior to drug administration (time 0), and 10, 20, 40 min and 1, 1.5, 2, 4, 6, 8, 12, 24, and 48 h after administration for analysis with high pressure liquid chromatography using ultraviolet detection. Following PO administration, deracoxib had a long elimination half-life (t(...
Atipamezole antagonism of an ACTH stimulation test in ponies sedated with detomidine.
Journal of veterinary pharmacology and therapeutics    November 22, 2010   Volume 34, Issue 5 508-511 doi: 10.1111/j.1365-2885.2010.01251.x
Luna SP, Taylor PM, Carregaro AB.No abstract available
Pharmacokinetics of ceftiofur sodium and ceftiofur crystalline free acid in neonatal foals.
Journal of veterinary pharmacology and therapeutics    November 18, 2010   Volume 34, Issue 4 403-409 doi: 10.1111/j.1365-2885.2010.01252.x
Hall TL, Tell LA, Wetzlich SE, McCormick JD, Fowler LW, Pusterla N.Ceftiofur, a third generation cephalosporin, demonstrates in vitro efficacy against microorganisms isolated from septicemic neonatal foals. This pharmacokinetic study evaluated the intravenous and subcutaneous administration of ceftiofur sodium (5 mg/kg body weight; n = 6 per group) and subcutaneous administration of ceftiofur crystalline free acid (6.6 mg/kg body weight; n = 6) in healthy foals. Plasma ceftiofur- and desfuroylceftiofur-related metabolite concentrations were measured using high performance liquid chromatography following drug administration. Mean (±SD) noncompartmental pharma...
Antimicrobial disposition in pulmonary epithelial lining fluid of horses, part III. cefquinome.
Journal of veterinary pharmacology and therapeutics    November 18, 2010   Volume 34, Issue 5 482-486 doi: 10.1111/j.1365-2885.2010.01248.x
Winther L, Baptiste KE, Friis C.Cefquinome concentrations, following intravenous and aerosol administration to horses, in pulmonary epithelial lining fluid (PELF) were examined and compared to plasma concentrations. Single dose of cefquinome sulphate (1 mg/kg) was administered intravenously to six horses followed by a single aerosol administration (225 mg) with a wash-out period of 14 days between treatments. After each drug administration, cefquinome concentrations in plasma and PELF, obtained by intrabronchial cotton swabs, were determined. After intravenous administration, cefquinome concentrations in plasma declined fast...
Pharmacokinetics and toxicity of ciprofloxacin in adult horses.
Journal of veterinary pharmacology and therapeutics    November 11, 2010   Volume 33, Issue 6 587-594 doi: 10.1111/j.1365-2885.2010.01167.x
Yamarik TA, Wilson WD, Wiebe VJ, Pusterla N, Edman J, Papich MG.Using a randomized, cross-over study design, ciprofloxacin was administered i.g. to eight adult mares at a dose of 20 mg/kg, and to seven of the eight horses at a dose of 5 mg/kg by bolus i.v. injection. The mean C(0) was 20.5 μg/mL (±8.8) immediately after i.v. administration. The C(max) was 0.6 μg/mL (±0.36) at T(max) 1.46 (±0.66) h after the administration of oral ciprofloxacin. The mean elimination half-life after i.v. administration was 5.8 (±1.6) h, and after oral administration the terminal half-life was 3.6 (±1.7) h. The overall mean systemic availability of ...
Bioavailability and pharmacokinetics of metronidazole in fed and fasted horses.
Journal of veterinary pharmacology and therapeutics    September 24, 2010   Volume 33, Issue 5 511-514 doi: 10.1111/j.1365-2885.2010.01171.x
Britzi M, Gross M, Lavy E, Soback S, Steinman A.No abstract available
Pharmacokinetic profile and behavioral effects of gabapentin in the horse.
Journal of veterinary pharmacology and therapeutics    September 16, 2010   Volume 33, Issue 5 485-494 doi: 10.1111/j.1365-2885.2010.01161.x
Terry RL, McDonnell SM, Van Eps AW, Soma LR, Liu Y, Uboh CE, Moate PJ, Driessen B.Gabapentin is being used in horses although its pharmacokinetic (PK) profile, pharmacodynamic (PD) effects and safety in the equine are not fully investigated. Therefore, we characterized PKs and cardiovascular and behavioral effects of gabapentin in horses. Gabapentin (20 mg/kg) was administered i.v. or p.o. to six horses using a randomized crossover design. Plasma gabapentin concentrations were measured in samples collected 0-48 h postadministration employing liquid chromatography-tandem mass spectrometry. Blood pressures, ECG, and sedation scores were recorded before and for 12 h after gaba...
Pharmacokinetics and pharmacodynamics of three intravenous doses of yohimbine in the horse.
Journal of veterinary pharmacology and therapeutics    September 10, 2010   Volume 34, Issue 4 359-366 doi: 10.1111/j.1365-2885.2010.01234.x
Dimaio Knych HK, Steffey EP, Stanley SD.Yohimbine is an alpha 2 adrenergic receptor antagonist, which has been shown to counteract the CNS depressant effects of alpha 2 receptor agonists in a number of species. Recently, our laboratory identified yohimbine in the absence of detectable concentrations of an alpha 2 agonist in a regulatory sample collected from a horse racing in California. This coupled with anecdotal reports of CNS stimulation and documented reports of cardiovascular changes when administered in conjunction with an agonist led us to investigate the pharmacokinetics and pharmacodynamics of yohimbine when administered a...
Antimicrobial disposition in pulmonary epithelial lining fluid of horses. Part I. Sulfadiazine and trimethoprim.
Journal of veterinary pharmacology and therapeutics    August 24, 2010   Volume 34, Issue 3 277-284 doi: 10.1111/j.1365-2885.2010.01228.x
Winther L, Guardabassi L, Baptiste KE, Friis C.Sulfadiazine (SDZ) and trimethoprim (TMP) concentrations were examined in plasma and pulmonary epithelial lining fluid (PELF), following intravenous and oral administration and compared to minimum inhibitory concentrations (MICs) of common bacterial isolates from equine lower airway infections. SDZ/TMP (25/5 mg/kg) was administered intravenously, intragastric or per os to fed horses, and blood samples were collected before and 11 times, over 24 h, after administration. PELF samples were collected via a tampon device four times after drug administration and analysed for drug concentrations. Add...
Antimicrobial disposition in pulmonary epithelial lining fluid of horses, part II. Doxycycline.
Journal of veterinary pharmacology and therapeutics    August 24, 2010   Volume 34, Issue 3 285-289 doi: 10.1111/j.1365-2885.2010.01229.x
Winther L, Honoré Hansen S, Baptiste KE, Friis C.Doxycycline concentrations, following two types of oral administration to horses, in pulmonary epithelial lining fluid (PELF) were examined and compared to plasma concentrations. The oral bioavailability was estimated from plasma concentrations achieved after an intravenous study in two horses. Doxycycline (10 mg/kg) was administered either intragastric or as topdressing to nonfasted horses. Blood samples were collected for drug analysis, before and 11 times after administration during 24 h. PELF samples were collected by a tampon device four times after drug administration and analysed for do...
Pharmacokinetics of aztreonam after intravenous administration in foals.
Journal of veterinary pharmacology and therapeutics    August 18, 2010   Volume 34, Issue 1 92-94 doi: 10.1111/j.1365-2885.2010.01221.x
Paxson JA, Paradis MR.No abstract available
Pharmacokinetics of an orally administered methylcellulose formulation of gallium maltolate in neonatal foals.
Journal of veterinary pharmacology and therapeutics    July 22, 2010   Volume 33, Issue 4 376-382 doi: 10.1111/j.1365-2885.2009.01150.x
Chaffin MK, Fajt V, Martens RJ, Arnold CE, Cohen ND, O'Conor M, Taylor RJ, Bernstein LR.Gallium is a trivalent semi-metal with anti-microbial effects because of its incorporation into crucial iron-dependent reproductive enzyme systems. Gallium maltolate (GaM) provides significant gallium bioavailability to people and mice following oral administration and to neonatal foals following intragastric administration. To study the prophylactic and therapeutic effects of GaM against Rhodococcus equi pneumonia in foals, we developed a methylcellulose formulation of GaM (GaM-MCF) for oral administration to neonatal foals. Normal neonatal foals were studied. Six foals received 20 mg/kg and ...
1 6 7 8 9 10 20